Gps Wealth Strategies Group, LLC Arbutus Biopharma Corp Transaction History

Gps Wealth Strategies Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$2.23 - $3.1 $1,561 - $2,170	700 New	700 $2,000
Q2 2022 Jul 19, 2022	SELL	$1.98 - $3.17 $2,306 - $3,693	-1,165 Reduced 62.47%	700 $2,000
Q1 2022 Apr 20, 2022	SELL	$2.42 - $3.98 $1,210 - $1,990	-500 Reduced 21.14%	1,865 $6,000
Q2 2021 Jul 19, 2021	SELL	$2.5 - $3.51 $2,500 - $3,510	-1,000 Reduced 29.72%	2,365 $7,000
Q1 2021 Apr 15, 2021	BUY	$3.14 - $4.84 $10,566 - $16,286	3,365 New	3,365 $11,000

138

95.5M

3.44M

377K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $577M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Gps Wealth Strategies Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Gps Wealth Strategies Group, LLC with notifications on news.